Treace Medical Concepts, Inc. (TMCI) Reports In-Line Q1 EPS

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q1 EPS of ($0.23), in-line with the analyst estimate of ($0.23). Revenue for the quarter came in at $42.2 million versus the consensus estimate of $39.25 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Southland Holdings (SLND) Misses Q2 EPS by 122c
• FGI Industries Ltd (FGI) Tops Q2 EPS by 59c